MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/wnf.0000000000000550

Медицинская библиотека · Clinical neuropharmacology · 2023

Medical Cannabis in the Treatment of Parkinson's Disease.

Aladeen Traci S, Mattle Anna G, Zelen Kory, Mesha Moustafa, Rainka Michelle M, Geist Tanya, Myers Bennett, Mechtler Laszlo

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Medical cannabis (MC) has recently garnered interest as a potential treatment for neurologic diseases, including Parkinson's disease (PD). A retrospective chart review was conducted to explore the impact of MC on the symptomatic treatment of patients with PD.

METHODS

Patients with PD treated with MC in the normal course of clinical practice were included (n = 69). Data collected from patient charts included MC ratio/formulation changes, PD symptom changes after initiation of MC, and adverse events (AEs) from MC use. Information regarding changes in concomitant medications after MC initiation, including opioids, benzodiazepines, muscle relaxants, and PD medications, was also collected.

RESULTS

Most patients were initially certified for a 1:1 (∆ 9 -tetrahydrocannabinol:cannabidiol) tincture. Eight-seven percent of patients (n = 60) were noted to exhibit an improvement in any PD symptom after starting MC. Symptoms with the highest incidence of improvement included cramping/dystonia, pain, spasticity, lack of appetite, dyskinesia, and tremor. After starting MC, 56% of opioid users (n = 14) were able to decrease or discontinue opioid use with an average daily morphine milligram equivalent change from 31 at baseline to 22 at the last follow-up visit. The MC was well-tolerated with no severe AEs reported and low rate of MC discontinuation due to AEs (n = 4).

CONCLUSIONS

The MC may improve motor and nonmotor symptoms in patients with PD and may allow for reduction of concomitant opioid medication use. Large, placebo-controlled, randomized studies of MC use in patients with PD are required.

Для цитирования: Aladeen Traci S, Mattle Anna G, Zelen Kory, Mesha Moustafa, Rainka Michelle M, Geist Tanya, Myers Bennett, Mechtler Laszlo. Medical Cannabis in the Treatment of Parkinson's Disease.. Clinical neuropharmacology. 2023. DOI: 10.1097/wnf.0000000000000550.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.